The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

Özet

Açıklama

Alıntı

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By